Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model

Antitumoral activity of allosteric inhibitors of Protein kinase CK2

(2015) Virginie Moucadel et al.   Oncotarget

CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival

(2011) Daniela P. Ponce et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

(2010) A. Siddiqui-Jain et al.   CANCER RESEARCH

Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library

(2009) Ming-Szu Hung et al.   BMC CANCER

The CK2α/CK2β Interface of Human Protein Kinase CK2 Harbors a Binding Pocket for Small Molecules

(2008) Jennifer Raaf et al.   CHEMISTRY & BIOLOGY

Insights from soft X-rays: the chlorine and sulfur sub-structures of a CK2α/DRB complex

(2008) Jennifer Raaf et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2

(2007) James S. Duncan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS